In 2021, the market for TB diagnostics was estimated to be worth USD 1.71 billion. The market is anticipated to expand at a CAGR of 6.1% from 2022 to 2029, rising from USD 2.07 billion in 2022 to USD 3.13 billion. The COVID-19 pandemic has had an unprecedented and shattering impact on the world, and demand for tuberculosis diagnostics has been lower than expected in all regions compared to pre-pandemic levels. Our investigation revealed that the global market had a decline of -21.5% in 2020 compared to 2019.
The severe bacterial infection tuberculosis is brought on by Mycobacterium tuberculosis. Usually, the sickness affects the patient's lungs. Along with other body parts, the infection can potentially harm the spine and the brain. The diagnosis of tuberculosis can be made through blood and skin tests.